Pain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational Study

ClinicoEconomics and Outcomes Research

Volumn 6, Issue , 2014, Pages 483-496

  Schaefer, Caroline ^a   Sadosky, Alesia ^b   Mann, Rachael ^c   Daniel, Shoshana ^d   Parsons, Bruce ^b   Tuchman, Michael ^e   Anschel, Alan ^f   Stacey, Brett R ^g   Nalamachu, Srinivas ^h   Nieshoff, Edward ⁱ  

^a Covance Market Access Services Inc   (United States)

^b PFIZER INC   (United States)

^c Department of Genetic and Molecular Toxicology   (United States)

^d Rehabilitation Institute of Chicago ^*  (United States)

^e Palm Beach Neurological Center   (United States)

^f REHABILITATION INSTITUTE OF CHICAGO   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^h Clinical Research   (United States)

ⁱ REHABILITATION INSTITUTE OF MICHIGAN   (United States)

Author keywords

Burden of illness; Health care costs; Health care resource use; Neuropathic pain management; Productivity

Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; BRIEF PAIN INVENTORY; COMORBIDITY; CROSS-SECTIONAL STUDY; DISABILITY; DISEASE ASSOCIATION; ECONOMIC ASPECT; ECONOMIC BURDEN; EDUCATIONAL STATUS; EMPLOYMENT STATUS; ETHNIC DIFFERENCE; FEMALE; GROUPS BY AGE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; OBSERVATIONAL STUDY; PAIN SEVERITY; PRODUCTIVITY; RETROSPECTIVE STUDY; UNITED STATES;

EID: 84908499486     PISSN: None     EISSN: 11786981     Source Type: Journal    
DOI: 10.2147/CEOR.S63323     Document Type: Article

References (34)

1. International Association for the Study of Pain. IASP taxonomy. Available from: http://www. iasp-pain. org/Content/NavigationMenu/GeneralResourceLinks/PainDefinitions/default. htm#Neuropathicpain. Accessed September 10, 2013.
2. Treede RD, Jensen T, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008; 70(18): 1630-1635.
3. International Association for the Study of Pain. Diagnosis and classification of neuropathic pain. Pain Clinical Updates. 2010; 18(7): 1-6.
4. Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain. 2004; 5(3): 143-149.
5. Gore M, Brandenburg N, Hoffman D, Tai KS, Stacey B. Burden of illness in painful diabetic peripheral neuropathy (DPN): the patients' perspective. J Pain. 2006; 7(12): 892-900.
6. Dworkin RH, Malone DC, Panarites CJ, Armstrong EP, Pham SV. Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs. J Pain. 2010; 11(4): 360-368.
7. Dworkin RH, Panarites CJ, Armstrong EP, Malone DC, Pham SV. Health care utilization in people with postherpetic neuralgia and painful diabetic peripheral neuropathy. J Am Geriatr Soc. 2011; 59(5): 827-836.
8. daCosta DiBonaventura M, Cappelleri JC, Joshi AV. A longitudinal assessment of painful diabetic peripheral neuropathy on health status, productivity, and health care utilization and cost. Pain Med. 2011; 12(1): 118-126.
9. daCosta DiBonaventura M, Cappelleri JC, Joshi AV. Association between pain severity and health care resource use, health status, productivity and related costs in painful diabetic peripheral neuropathy patients. Pain Med. 2011; 12(5): 799-807.
10. Finnerup N, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005; 118(3): 289-305.
11. Dworkin RH, O'Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010; 85 Suppl 3: S3-S14.
12. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010; 17(9): 1113-1123.
13. Sadosky A, Schaefer C, Mann R, et al. Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey. Diabetes Metab Syndr Obes. 2013; 6: 79-92.
14. Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai KS, Stacey B. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage. 2005; 30(4): 374-385.
15. Taylor-Stokes G, Pike J, Sadosky A, Chandran A, Toelle T. Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy. Diabetes Metab Syndr Obes. 2011; 4: 401-408.
16. World Medical Association. Declaration of Helsinki. Adopted by the 18th World Medical Assembly (WMA) General Assembly H, Finland, 1964; amended by the 29th WMA General Assembly in Tokyo, Japan in 1975, the 35th WMA General Assembly in Venice, Italy in 1983, the 41st WMA General Assembly in Hong Kong in 1989, the 48th WMA General Assembly in Somerset West, Republic of South Africa in 1996, and the 52nd WMA General Assembly in Edinburgh, Scotland, 2000. Available from: http://www. wma. net/en/30publications/10policies/b3/index. html. Accessed February 20, 2014.
17. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994; 23(2): 129-138.
18. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993; 4(5): 353-365.
19. Zelman D, Dukes E, Brandenburg N, Bostrom A, Gore M. Classification of mild, moderate and severe pain due to diabetic peripheral neuropathy based on levels of functional disability [abstract]. J Pain. 2004; 5 Suppl 1: 114.
20. Zelman D, Dukes E, Brandenburg N, Bostrom A, Gore M. Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy. Pain. 2005; 115(2): 29-36.
21. Ware JE Jr, Kosinski M, Turner-Bowker D, Sundaram M, Gandek B, Maruish ME. User's Manual for the SF-12v2 Health Survey Second Edition. 2nd ed. Lincoln, RI, USA: QualityMetric Incorporated; 2009.
22. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001; 33(5): 337-343.
23. Hays RD, Martin SA, Sesti AM, Spritzer KL. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med. 2005; 6(1): 41-44.
24. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression scale. Acta Psychiatr Scand Suppl. 1983; 67(6): 361-370.
25. Evans CJ, Trudeau E, Mertzanis P, et al. Development and validation of the Pain Treatment Satisfaction Scale (PTSS): a patient satisfaction questionnaire for use in patients with chronic or acute pain. Pain. 2004; 112(3): 254-266.
26. Schaefer C, Mann R, Sadosky A, et al. Burden of illness associated with peripheral and central neuropathic pain among adults seeking treatment in the United States: a patient-centered evaluation. Pain Medicine. In press 2014.
27. United States Department of Labor. United States Bureau of Labor Statistics. May 2011 National Occupational Employment and Wage Estimates United States, 2012. Available from: http://www. bls. gov/oes/2011/may/oes_nat. htm. Accessed July 26, 2012.
28. United States Social Security Administration Office of Retirement and Disability Policy. Annual Statistical Supplement, 2011. Old-Age, Survivors, and Disability Insurance. Table 5. D1. Available from: http://www. ssa. gov/policy/docs/statcomps/supplement/2011/5d. html. Accessed April 23, 2012.
29. Lofland JH, Pizzi L, Frick KD. A review of health-related workplace productivity loss instruments. Pharmacoeconomics. 2004; 22(3): 165-184.
30. Mann R, Schaefer C, Sadosky A, et al. Burden of spinal cord injury-related neuropathic pain in the United States: retrospective chart review and cross-sectional survey. Spinal Cord. 2013; 51(7): 564-570.
31. Parsons B, Schaefer C, Mann R, et al. Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United States. J Pain Res. 2013; 6: 459-469.
32. Schaefer C, Mann R, Sadosky A, et al. Health status, function, productivity, and costs among individuals with idiopathic painful peripheral neuropathy with small fiber involvement in the United States: results from a retrospective chart review and cross-sectional survey. J Med Econ. 2014: 1-14.
33. Gore M, Tai KS, Zlateva G, Bala Chandran A, Leslie D. Clinical characteristics, pharmacotherapy, and health care resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin. Pain Pract. 2011; 11(6): 528-539.
34. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003; 290(18): 2443-2454.